25.5.2012   

DA

Den Europæiske Unions Tidende

C 148/1

Oversigt over EU-afgørelser om tilladelse til markedsføring af lægemidler fra 1. april 2012 til 30. april 2012

(Offentliggjort i henhold til artikel 13 eller artikel 38 i Europa-Parlamentets og Rådets forordning (EF) nr. 726/2004  (1) )

2012/C 148/01

—   Udstedelse af markedsføringstilladelse (artikel 13 i Europa-Parlamentets og Rådets forordning (EF) nr. 726/2004): Godkendt

Dato for afgørelser

Lægemidlets navn

INN-navn (International Non-Proprietary Name)

Indehaver af markedsføringstilladelsen

Nummer i EF-registret

Lægemiddelform

ATC-kode (Anatomical Therapeutic Chemical Code)

Dato for notifikation

13.4.2012

Bronchitol

Mannitol

Pharmaxis Pharmaceuticals Limited

The Priory, Stomp Road, Burnham,

Buckinghamshire,

SL1 7LW,

United Kingdom

EU/1/12/760/001-002

Inhalationspulver i kapsel

R05CB16

18.4.2012

13.4.2012

Sabervel

Irbesartan

Pharmathen S.A.

6 Dervenakion,

15351 Pallini Attiki,

Ελλάδα

EU/1/12/765/001-006

Filmovertrukket tablet

C09CA04

17.4.2012

20.4.2012

Capecitabine Accord

capecitabin

Accord Healthcare Limited

Sage house, 319 Pinner road, North Harrow,

Middlesex

HA1 4HF

United Kingdom

EU/1/12/762/001-018

Filmovertrukket tablet

L01BC06

25.4.2012

20.4.2012

Capecitabine Krka

capecitabin

KRKA, d.d

Novo mesto, Šmarješka cesta 6,

8501 Novo mesto,

Slovenia

EU/1/12/763/001-018

Filmovertrukket tablet

L01BC06

25.4.2012

20.4.2012

Capecitabine Teva

capecitabin

TEVA Pharma B.V.

Computerweg 10,

3542 DR Utrecht,

Nederland

EU/1/12/761/001-002

Filmovertrukket tablet

L01BC06

25.4.2012

20.4.2012

Nimenrix

Meningokokgruppe A, C, W-135 og Y konjugeret vaccine

GlaxoSmithKline Biologicals S.A.

Rue de l'Institut 89,

1330 Rixensart,

Belgique

EU/1/12/767/001-007

Pulver og solvens til opløsning, injektion

J07AH08

25.4.2012

20.4.2012

SANCUSO

Granisetron

ProStrakan Limited

Galabank Business Park,

Galashiels,

TD1 1QH,

United Kingdom

EU/1/12/766/001

Depotplaster

A04AA02

25.4.2012

20.4.2012

Zoledronic acid Actavis

Zoledronsyre

Actavis Group PTC ehf.

ReykjavÍkurvegur 76-78,

Hafnarfjörður 220,

Iceland

EU/1/12/759/001-003

Koncentrat till infusionsvaeske, opløsning

M05BA08

26.4.2012

24.4.2012

Signifor

pasireotid

Novartis Europharm Limited

Wimblehurst Road, Horsham,

West Sussex,

RH12 5AB,

United Kingdom

EU/1/12/753/001-012

Injektionsvœske, opløsning

H01CB05

27.4.2012


—   Ændring af markedsføringstilladelse (artikel 13 i Europa-Parlamentets og Rådets forordning (EF) nr. 726/2004): Godkendt

Dato for afgørelser

Lægemidlets navn

Indehaver af markedsføringstilladelsen

Nummer i EF-registret

Dato for notifikation

3.4.2012

Kinzalkomb

Bayer Pharma AG

13342 Berlin

Deutschland

EU/1/02/214/001-015

5.4.2012

4.4.2012

Humira

Abbott Laboratories Ltd

Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead

Berkshire

SL6 4XE,

United Kingdom

EU/1/03/256/001-010

10.4.2012

4.4.2012

Plavix

Sanofi Pharma Bristol-Myers Squibb SNC

174 avenue de France -

75013 Paris,

France

EU/1/98/069/001a-001b

EU/1/98/069/002a-002b

EU/1/98/069/003a-003b

EU/1/98/069/004a-004b

EU/1/98/069/005a-005b

EU/1/98/069/006a-006b

EU/1/98/069/007a-007b

EU/1/98/069/008-010

EU/1/98/069/011a-011b

EU/1/98/069/012

11.4.2012

4.4.2012

Rebetol

Schering Plough Europe

Clos du Lynx 5,

1200 Bruxelles,

Belgique –

Lynx Binnenhof 5,

1200 Brussel,

België

EU/1/99/107/001-005

11.4.2012

4.4.2012

Telzir

ViiV Healthcare UK Ltd

980 Great West Road, Brentford,

Middlesex,

TW8 9GS,

United Kingdom

EU/1/04/282/001-002

11.4.2012

10.4.2012

Vedrop

Orphan Europe SARL

Immeuble Le Wilson -

70 Avenue du Général de Gaulle -

F 92 800 Puteaux -

France

EU/1/09/533/001-003

12.4.2012

13.4.2012

Advagraf

Astellas Pharma Europe B.V.

Elisabethhof 19,

NL-2353 EW Leiderdorp,

Nederland

EU/1/07/387/001-026

17.4.2012

13.4.2012

alli

Glaxo Group Limited

Glaxo Wellcome House, Berkeley Avenue, Greenford,

Middlesex

UB6 0NN,

United Kingdom

EU/1/07/401/007-016

17.4.2012

13.4.2012

Champix

Pfizer Ltd

Ramsgate Road, Sandwich,

Kent

CT 13 9NJ,

United Kingdom

EU/1/06/360/001-013

17.4.2012

13.4.2012

Evoltra

Genzyme Europe BV

Gooimeer 10,

1411 DD Naarden,

Nederland

EU/1/06/334/001-005

17.4.2012

13.4.2012

Foscan

Biolitec pharma Ltd

United Drug House, Magna Drive,

Dublin 24,

Ireland

EU/1/01/197/003-005

17.4.2012

13.4.2012

Pradaxa

Boehringer Ingelheim International GmbH

Binger Strasse 173,

D-55216 Ingelheim am Rhein,

Deutschland

EU/1/08/442/001-014

17.4.2012

13.4.2012

Prometax

Novartis Europharm Ltd

Wimblehurst Road, Horsham,

West Sussex

RH12 5AB,

United Kingdom

EU/1/98/092/001-026

17.4.2012

13.4.2012

Revatio

Pfizer Limited

Sandwich,

Kent,

CT13 9NJ,

United Kingdom

EU/1/05/318/001

17.4.2012

13.4.2012

Revlimid

Celgene Europe Limited

1 Longwalk Road, Stockley Park, Uxbridge,

Middlesex,

UB11 1DB,

United Kingdom

EU/1/07/391/001-004

17.4.2012

13.4.2012

Soliris

Alexion Europe S.A.S.

25, boulevard de l'Amiral Bruix,

75016 Paris,

France

EU/1/07/393/001

17.4.2012

13.4.2012

Tyverb

Glaxo Group Limited

Berkeley Avenue, Greenford,

Middlesex

UB6 0NN,

United Kingdom

EU/1/07/440/001-006

17.4.2012

13.4.2012

Viramune

Boehringer Ingelheim International GmbH

Binger Strasse 173-

D - 55216 Ingelheim am Rhein,

Deutschland

EU/1/97/055/001-009

17.4.2012

13.4.2012

Volibris

Glaxo Group Ltd

Greenford,

Middlesex

UB6 0NN,

United Kingdom

EU/1/08/451/001-004

17.4.2012

20.4.2012

Abraxane

Celgene Europe Limited

1 Longwalk Road, Stockley Park, Uxbridge,

Middlesex,

UB11 1DB,

United Kingdom

EU/1/07/428/001

24.4.2012

20.4.2012

Aclasta

Novartis Europharm Ltd

Wimblehurst Road, Horsham,

West Sussex

RH12 5AB,

United Kingdom

EU/1/05/308/001-002

25.4.2012

20.4.2012

Aflunov

Novartis Vaccines and Diagnostics S.r.l.

Via Fiorentina, 1,

53100 Siena,

Italia

EU/1/10/658/001-002

26.4.2012

20.4.2012

Altargo

Glaxo Group Limited

Glaxo Wellcome House, Berkeley Avenue, Greenford,

Middlesex

UB6 0NN,

United Kingdom

EU/1/07/390/001-004

26.4.2012

20.4.2012

Apidra

Sanofi-Aventis Deutschland GmbH

D-65926 Frankfurt am Main,

Deutschland

EU/1/04/285/001-036

26.4.2012

20.4.2012

Ceplene

EpiCept GmbH

Goethestrasse 4,

D-80336 München,

Deutschland

EU/1/08/477/001

24.4.2012

20.4.2012

Circadin

RAD Neurim Pharmaceuticals EEC Limited

One Forbury Square, The Forbury, Reading,

Berkshire

RG1 3EB,

United Kingdom

EU/1/07/392/001-003

25.4.2012

20.4.2012

Exelon

Novartis Europharm Ltd

Wimblehurst Road, Horsham,

West Sussex

RH12 5AB,

United Kingdom

EU/1/98/066/001-026

26.3.2012

20.4.2012

Focetria

Novartis Vaccines and Diagnostics S.r.l.

Via Fiorentina, 1,

53100 Siena,

Italia

EU/1/07/385/001-002

EU/1/07/385/004

26.4.2012

20.4.2012

HALAVEN

Eisai Europe Limited

European Knowledge Centre, Mosquito Way, Hatfield,

Herts

AL10 9SN,

United Kingdom

EU/1/11/678/001-002

25.4.2012

20.4.2012

Helixate NexGen

Bayer Pharma AG

13342 Berlin,

Deutschland

EU/1/00/144/001-005

25.4.2012

20.4.2012

Humira

Abbott Laboratories Ltd

Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead,

Berkshire

SL6 4XE,

United Kingdom

EU/1/03/256/002-010

25.4.2012

20.4.2012

Insulin Human Winthrop

Sanofi-Aventis Deutschland GmbH

D-65926 Frankfurt am Main,

Deutschland

EU/1/06/368/001-015

EU/1/06/368/020-024

EU/1/06/368/029-033

EU/1/06/368/037-042

EU/1/06/368/047-051

EU/1/06/368/056-057

EU/1/06/368/088-102

EU/1/06/368/113-150

EU/1/06/368/163-168

25.4.2012

20.4.2012

Insuman

Sanofi-Aventis Deutschland GmbH

D-65926 Frankfurt am Main,

Deutschland

EU/1/97/030/028-195

26.4.2012

20.4.2012

IOA

N.V. Organon

Kloosterstraat 6,

5349 AB Oss,

Nederland

EU/1/11/689/001-002

24.4.2012

20.4.2012

Iressa

AstraZeneca AB

S 151 85 Sodertalje,

Sverige

EU/1/09/526/001-002

26.4.2012

20.4.2012

Kogenate Bayer

Bayer Pharma AG

13342 Berlin,

Deutschland

EU/1/00/143/004-013

25.4.2012

20.4.2012

Lantus

Sanofi-Aventis Deutschland GmbH

D-65926 Frankfurt am Main,

Deutschland

EU/1/00/134/001-037

25.4.2012

20.4.2012

Norvir

Abbott Laboratories Ltd

Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead,

Berkshire

SL6 4XE,

United Kingdom

EU/1/96/016/001

EU/1/96/016/003-008

26.4.2012

20.4.2012

NovoNorm

Novo Nordisk A/S

Novo Allé,

DK-2880 Bagsvaerd,

Danmark

EU/1/98/076/004-006

EU/1/98/076/011-013

EU/1/98/076/018-020

EU/1/98/076/022-024

26.3.2012

20.4.2012

Opgenra

Olympus Biotech International Limited

Raheen Business Park, Limerick,

Ireland

EU/1/08/489/001-002

24.4.2012

20.4.2012

Optimark

Covidien Deutschland GmbH

Gewerbepark 1,

93333 Neustadt/Donau,

Deutschland

EU/1/07/398/001-014

26.3.2012

20.04.2012

Optisulin

Sanofi-Aventis Deutschland GmbH

D-65926 Frankfurt am Main,

Deutschland

EU/1/00/133/001-032

25.4.2012

20.4.2012

Pelzont

Merck Sharp & Dohme Ltd

Hertford Road, Hoddesdon,

Hertfordshire

EN11 9BU,

United Kingdom

EU/1/08/460/001-014

25.4.2012

20.4.2012

Prandin

Novo Nordisk A/S

Novo Allé,

DK-2880 Bagsvaerd,

Danmark

EU/1/00/162/003-005

EU/1/00/162/009-011

EU/1/00/162/015-017

EU/1/00/162/019-021

26.4.2012

20.4.2012

Preotact

Nycomed Danmark ApS

Langebjerg 1,

DK-4000 Roskilde,

Danmark

EU/1/06/339/001-003

25.4.2012

20.4.2012

Prolia

Amgen Europe B.V.

Minervum 7061,

NL-4817 ZK Breda,

Nederland

EU/1/10/618/001-004

24.4.2012

20.4.2012

ProQuad

Sanofi Pasteur MSD, SNC

8, rue Jonas Salk,

69007 Lyon,

France

EU/1/05/323/001-013

26.4.2012

20.4.2012

Rasilamlo

Novartis Europharm Ltd

Wimblehurst Road, Horsham,

West Sussex,

RH12 5AB,

United Kingdom

EU/1/11/686/001-056

24.4.2012

20.4.2012

Rasilez

Novartis Europharm Ltd

Wimblehurst Road, Horsham,

West Sussex

RH12 5AB,

United Kingdom

EU/1/07/405/001-040

24.4.2012

20.4.2012

Riprazo

Novartis Europharm Ltd

Wimblehurst Road, Horsham,

West Sussex

RH12 5AB,

United Kingdom

EU/1/07/409/001-040

24.4.2012

20.4.2012

Riprazo HCT

Novartis Europharm Limited

Wimblehurst Road, Horsham,

West Sussex,

RH12 5AB,

United Kingdom

EU/1/11/680/001-080

24.4.2012

20.4.2012

Samsca

Otsuka Pharmaceutical Europe Ltd

Hunton House, Highbridge Business Park, Oxford Road, Uxbridge,

Middlesex

UB8 1LX,

United Kingdom

EU/1/09/539/001-004

24.4.2012

20.4.2012

Sebivo

Novartis Europharm Ltd

Wimblehurst Road, Horsham,

West Sussex

RH12 5AB,

United Kingdom

EU/1/07/388/001-003

26.4.2012

20.4.2012

Silodyx

Recordati Ireland Ltd.

Raheens East, Ringaskiddy Co. Cork,

Ireland

EU/1/09/607/001-014

24.4.2012

20.4.2012

Sprimeo

Novartis Europharm Ltd

Wimblehurst Road, Horsham,

West Sussex

RH12 5AB,

United Kingdom

EU/1/07/407/001-040

24.4.2012

20.4.2012

Sprimeo HCT

Novartis Europharm Limited

Wimblehurst Road, Horsham,

West Sussex,

RH12 5AB,

United Kingdom

EU/1/11/683/001-080

24.4.2012

20.4.2012

Tracleer

Actelion Registration Ltd

BSI Building 13th Floor, 389 Chiswick High Road,

London

W4 4AL,

United Kingdom

EU/1/02/220/001-006

26.4.2012

20.4.2012

Tredaptive

Merck Sharp & Dohme Ltd

Hertford Road, Hoddesdon,

Hertfordshire

EN11 9BU,

United Kingdom

EU/1/08/459/001-014

25.4.2012

20.4.2012

Trevaclyn

Merck Sharp & Dohme Ltd

Hertford Road, Hoddesdon,

Hertfordshire

EN11 9BU,

United Kingdom

EU/1/08/458/001-014

25.4.2012

20.4.2012

Urorec

Recordati Ireland Ltd.

Raheens East, Ringaskiddy Co. Cork,

Ireland

EU/1/09/608/001-014

24.4.2012

20.4.2012

Ventavis

Bayer Pharma AG

13342 Berlin,

Deutschland

EU/1/03/255/001-008

26.4.2012

20.4.2012

Vfend

Pfizer Ltd

Ramsgate Road, Sandwich,

Kent

CT 13 9NJ,

United Kingdom

EU/1/02/212/001-026

25.4.2012

20.4.2012

Victoza

Novo Nordisk A/S

Novo Allé,

DK-2880 Bagsvaerd,

Danmark

EU/1/09/529/001-005

24.4.2012

20.4.2012

Vidaza

Celgene Europe Ltd

1 Longwalk Road, Stockley Park,

Uxbridge,

UB11 1DB,

United Kingdom

EU/1/08/488/001

24.4.2012

20.4.2012

Xenical

Roche Registration Limited

6 Falcon Way, Shire Park, Welwyn

Garden City,

AL7 1TW,

United Kingdom

EU/1/98/071/001-006

24.4.2012

20.4.2012

Yttriga

Eckert & Ziegler Radiopharma GmbH

Robert-Rössle-Str. 10,

13125 Berlin,

Deutschland

EU/1/05/322/001-002

26.4.2012

20.4.2012

Zoely

Theramex S.r.l.

Via Messina 38,

20154 Milano,

Italia

EU/1/11/690/001-002

24.4.2012

24.4.2012

Menveo

Novartis Vaccines and Diagnostics S.r.l.

Via Fiorentina, 1,

53100 Siena,

Italia

EU/1/10/614/001-003

27.4.2012

24.4.2012

Rasilez HCT

Novartis Europharm Ltd

Wimblehurst Road, Horsham,

West Sussex

RH12 5AB,

United Kingdom

EU/1/08/491/001-080

27.4.2012

24.4.2012

Temomedac

medac Gesellschaft für klinische Spezialpräparate mbH

Fehlandtstrasse 3,

D-20354 Hamburg -

Deutschland

EU/1/09/605/001-012

27.4.2012

26.4.2012

Revolade

GlaxoSmithKline Trading Services Limited

6900 Cork Airport Business Park, Kinsale Road, Cork,

Ireland

EU/1/10/612/001-006

30.4.2012

26.4.2012

Yervoy

Bristol-Myers Squibb Pharma EEIG

Uxbridge Business Park, Sanderson Road,

Uxbridge

UB8 1DH,

United Kingdom

EU/1/11/698/001-002

30.4.2012


—   Tilbagekaldelse af markedsføringstilladelse (artikel 13 i Europa-Parlamentets og Rådets forordning (EF) nr. 726/2004)

Dato for afgørelser

Lægemidlets navn

Indehaver af markedsføringstilladelsen

Nummer i EF-registret

Dato for notifikation

20.4.2012

PhotoBarr

Pinnacle Biologics B.V.

p/a Trust Company Amsterdam B.V., Crystal Tower 21st Floor, Orlyplein 10,

1043 DP Amsterdam,

Nederland

EU/1/04/272/001-002

25.4.2012

24.4.2012

Refludan

Celgene Europe Ltd

1 Longwalk Road, Stockley Park,

Uxbridge,

UB11 1DB,

United Kingdom

EU/1/97/035/001-004

27.4.2012


—   Ændring af markedsføringstilladelse (artikel 38 i Europa-Parlamentets og Rådets forordning (EF) nr. 726/2004): Godkendt

Dato for afgørelser

Lægemidlets navn

Indehaver af markedsføringstilladelsen

Nummer i EF-registret

Dato for notifikation

10.4.2012

Slentrol

Pfizer Ltd

Ramsgate Road, Sandwich,

Kent

CT 13 9NJ,

United Kingdom

EU/2/07/071/001-003

12.4.2012

13.4.2012

Cerenia

Pfizer Ltd

Ramsgate Road, Sandwich,

Kent

CT 13 9NJ,

United Kingdom

EU/2/06/062/005

17.4.2012

20.4.2012

BTVPUR AlSap 1

MERIAL

29 avenue Tony Garnier,

69007 LYON,

France

EU/2/10/112/001-005

25.4.2012

20.4.2012

BTVPUR AlSap 1-8

MERIAL

29 avenue Tony Garnier,

69007 LYON,

France

EU/2/10/113/001-005

25.4.2012

20.4.2012

Loxicom

Norbrook Laboratories Limited

Station Works, Newry,

Co. Down,

BT35 6JP,

United Kindgom

EU/2/08/090/001-027

24.4.2012

20.4.2012

Meloxivet

Janssen Pharmaceutica N.V.

Turnhoutseweg 30,

B-2340 Beerse,

België

EU/2/07/077/001-005

25.4.2012

Alle interesserede kan ved henvendelse på nedenstående adresse få tilsendt den offentlige evalueringsrapport om de pågældende lægemidler og de afgørelser, der er truffet vedrørende disse:

The European Medicines Agency

7, Westferry Circus,

Canary Wharf

UK - LONDON E14 4H

(1)  EUT L 136 af 30.4.2004, s. 1.